Linklaters advises Tate & Lyle on its £2.7bn recommended cash offer by Ingredion Incorporated

Linklaters is pleased to be advising longstanding client Tate & Lyle, a leading global speciality food and beverage solutions business, on its £2.7bn recommended cash offer by Ingredion Incorporated. Under the transaction, Tate & Lyle shareholders will receive total value of 615 pence per Tate & Lyle share. This follows the announcement on 14 May 2026 by Tate & Lyle that it was in discussions with Ingredion in respect of a possible cash offer.

The transaction remains subject to the satisfaction of customary conditions, including shareholder approval and regulatory clearances and is expected to complete in the second half of 2027.

This is the latest in a series of significant transactions that Linklaters has advised Tate & Lyle on including its disposal of its Primary Products business, Primient, in the Americas and its acquisition of CP Kelco from J.M. Huber Corporation.

The cross-practice deal team is led by Global Head of Corporate Simon Branigan and Corporate Partner Lisa Chang, supported by managing associate Cameron Western (Corporate). Partners Thomas McGrath, Natura Gracia and John Eichlin (Antitrust & Foreign Investment) and Partners Cara Hegarty and Sinead Casey (Employment & Incentives) are also advising.

Simon Branigan, Global Head of Corporate, said: 

“Tate & Lyle is a longstanding Linklaters client and we are very pleased to support them throughout this landmark transaction. Our end-to-end corporate offer and global platform means we are able to bring together leading transactional expertise with complex, specialist advice from across our practices.”